Showing 11,801 - 11,820 results of 63,407 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 10 ((nn decrease) OR (mean decrease)) ))', query time: 0.92s Refine Results
  1. 11801

    Decreased abundances of mycorrhizal fungi and Gram-negative bacteria during RS-EX treatment as determined by phospholipid fatty acid (PLFA) analyses of soil samples. by Meike Siebers (4338715)

    Published 2018
    “…Marker fatty acids for different taxonomic groups are listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0200160#pone.0200160.s012" target="_blank">S2 Table</a>. …”
  2. 11802
  3. 11803
  4. 11804

    Image_2_TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1.tif by Rongkun Li (6286547)

    Published 2021
    “…Tripartite motif-containing 50 (TRIM50) is a member of the TRIM family, but little is known regarding its expression and potential functional roles in cancer. …”
  5. 11805

    Image_1_TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1.tif by Rongkun Li (6286547)

    Published 2021
    “…Tripartite motif-containing 50 (TRIM50) is a member of the TRIM family, but little is known regarding its expression and potential functional roles in cancer. …”
  6. 11806

    Image_3_TRIM50 Suppresses Pancreatic Cancer Progression and Reverses the Epithelial-Mesenchymal Transition via Facilitating the Ubiquitous Degradation of Snail1.tif by Rongkun Li (6286547)

    Published 2021
    “…Tripartite motif-containing 50 (TRIM50) is a member of the TRIM family, but little is known regarding its expression and potential functional roles in cancer. …”
  7. 11807
  8. 11808
  9. 11809

    In vivo assessment of combination of YM155 and sorafenib using a patient-derived RCC xenograft model in SCID mice. by Mei Yi Sim (4067998)

    Published 2017
    “…(A) The mean tumour volume of vehicle-, YM155-, sorafenib- and (YM155-sorafenib)- treated mice at the given time-points showed a decrease in the rate of tumour growth when compared to the vehicle control. …”
  10. 11810
  11. 11811
  12. 11812
  13. 11813
  14. 11814
  15. 11815
  16. 11816
  17. 11817
  18. 11818
  19. 11819
  20. 11820